[Evolution of antihypertensive therapy with calcium antagonists: the new molecules].
Pirrelli
A
A
DIMO, Cattedra di Medicina Interna, Università degli Studi, Bari.
Vulpis
V
V
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D020748:Mibefradil; D013764:Tetrahydronaphthalenes / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D002121:Calcium Channel Blockers; D013764:Tetrahydronaphthalenes; D020748:Mibefradil
Evoluzione del trattamento antipertensivo con calcioantagonisti: le nuove molecole.